NASDAQ$ACHC

Acadia Healthcare Company Inc. · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Acadia Healthcare showcased strong financial results and strategic progress in Q3 2023, with revenue growth and advancements in facility expansion and joint ventures.

Acadia Healthcare reported a revenue of $750.3 million, a 12.5% increase year-over-year, and a net loss of $217.7 million, which included a $394.2 million legal settlement expense. Adjusted income was $83.9 million, with adjusted EBITDA at $175.9 million, reflecting strong operational execution and growth strategy.

  • Revenue increased by 12.5% to $750.3 million compared to Q3 2022.
  • Same facility revenue grew by 13.0% year-over-year.
  • Net loss attributable to Acadia was $217.7 million, impacted by legal settlements.
  • Adjusted EBITDA increased by 13.4% to $175.9 million compared to Q3 2022, excluding income from the Provider Relief Fund.

Headline financials

Total Revenue

$750M

Previous: $667M+12.5%
EPS (adj)

$0.91

Previous: $0.80+13.7%
US Same-Facility Rev. Growth

13.0%

Previous: 10.2%+27.5%
US Same-Facility Patient Days Growth

6.0%

Previous: 3.1%+93.5%
US Same-Facility Rev/Day Growth

6.6%

Previous: 6.9%-4.3%
Capital Expenditures

-$285M

Previous: -$209M-36.7%
Free Cash Flow

-$503M

Previous: -$138M-265.4%
Net Income

-$218M

Previous: $71.1M-406.2%
Operating Income

-$149M

Previous: -$211M+29.4%
Gross Profit

$180M

Previous: $289M-37.7%
Cash & Equivalents

$99.6M

Previous: $93.4M+6.6%
Total Assets

$5.35B

Previous: $4.94B+8.2%
Stock-Based Comp

$8.16M

Previous: $7.24M+12.7%

Revenue & EPS history

Acadia Healthcare · Revenue · Quarterly

$750M

Q3 2023+12.5%vs Q3 2022
Beat estimate in 10 of 14 quarters(71%)
ActualEstimate

Forward guidance

Acadia updated its 2023 financial guidance, projecting revenue between $2.90 to $2.92 billion and adjusted earnings per diluted share between $3.33 to $3.43, while affirming guidance for interest expense, tax rate, and capital expenditures.

Tailwinds

  • Revenue: $2.90 to $2.92 billion
  • Adjusted EBITDA (excluding PRF income): $665 to $675 million
  • Adjusted earnings per diluted share (excluding PRF income): $3.33 to $3.43
  • Interest expense: $82 to $85 million
  • Tax rate: 25% to 26%

Headwinds

  • Expansion capital expenditures: $300 to $350 million
  • Depreciation and amortization expense: $125 to $135 million
  • Stock compensation expense: $30 to $35 million
  • Maintenance capital expenditures: $40 to $50 million
  • IT capital expenditures: $35 to $45 million

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

+1.5%

Avg return

Earnings day

+1.4%

Avg return

5 days after

+2.5%

Avg return

30 days after

60%

38 / 63 earnings

Positive

+23.1%

Q3 2020

Best reaction

-26.9%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.5%+0.3%-16.0%
Q4 2025+21.4%+36.5%+33.4%
Q3 2025-5.5%-10.2%-25.2%
Q1 2025+4.2%+1.2%-14.4%
Q4 2024-25.5%-26.3%-25.2%
Q3 2024-17.3%-18.0%-21.3%
Q2 2024+10.0%+5.4%+21.6%
Q1 2024-9.8%-8.3%-6.8%
Q4 2023-2.4%-1.8%-7.3%
Q3 2023-1.7%+1.1%+0.5%
Q2 2023+7.8%+6.5%+2.9%
Q1 2023-1.3%-4.4%-6.0%
Q4 2022-9.6%-7.3%-12.1%
Q3 2022-3.4%-5.5%+7.2%
Q2 2022+3.6%+3.9%+4.8%
Q1 2022+8.0%+5.4%+6.4%
Q4 2021+6.5%+9.3%+15.3%
Q3 2021+10.5%+11.8%+3.0%
Q2 2021+3.1%+1.3%+8.0%
Q1 2021-1.1%+1.1%+4.4%
Q4 2020+1.5%+2.5%+6.0%
Q3 2020+23.1%+28.7%+49.1%
Q2 2020+2.3%+2.7%-0.1%
Q1 2020+16.7%+18.2%+26.7%
Q4 2019-5.9%+6.0%+100.5%
Q3 2019-3.5%-2.0%+2.5%
Q2 2019-3.3%-12.0%-19.6%
Q1 2019+0.0%+3.2%+1.4%
Q4 2018+15.9%+11.7%+11.7%
Q3 2018-12.8%-5.0%-26.0%
Q2 2018-10.6%-7.4%-8.0%
Q1 2018+9.0%+11.7%+13.0%
Q4 2017+8.5%+6.8%+8.4%
Q3 2017-26.9%-25.6%-30.7%
Q2 2017+7.6%+5.7%-7.5%
Q1 2017-3.1%+0.0%-2.4%
Q4 2016+5.4%+4.9%-1.7%
Q3 2016+3.1%+3.8%+5.9%
Q2 2016-1.3%-0.8%-4.8%
Q1 2016-0.8%
Q4 2015+5.7%
Q3 2015+9.4%
Q2 2015+3.4%
Q1 2015-2.9%
Q4 2014-0.4%
Q3 2014+11.2%
Q2 2014-2.1%
Q1 2014+0.4%
Q4 2013-2.8%
Q3 2013+9.0%
Q2 2013+8.2%
Q1 2013+2.9%
Q4 2009+2.3%
Q4 2012+0.1%
Q3 2012+2.3%
Q2 2012+7.5%
Q2 2011+4.4%
Q1 2012+6.5%
Q1 2011-1.0%
Q4 2011+3.3%
Q4 2010+0.1%
Q3 2011+0.1%
Q3 2010+0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro